These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1686758)

  • 61. Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons.
    Zhang J; Chiodo LA; Freeman AS
    Brain Res; 1992 Sep; 590(1-2):153-63. PubMed ID: 1422830
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux.
    Nissbrandt H; Elverfors A; Engberg G
    Synapse; 1994 Aug; 17(4):217-24. PubMed ID: 7992197
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential subsensitivity of dopaminergic and neostriatal neurons to apomorphine with long-term treatment.
    Rebec GV; Lee EH
    Brain Res; 1982 Oct; 250(1):188-92. PubMed ID: 7139316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A quantitative correlation between single unit activity and fluorescence intensity of dopamine neurones in zona compacta of substantia nigra, as demonstrated under the influence of nicotine and physostigmine.
    Lichtensteiger W; Felix D; Lienhart R; Hefti F
    Brain Res; 1976 Nov; 117(1):85-103. PubMed ID: 990937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of dopamine re-uptake: significance for nigral dopamine neuron activity.
    Engberg G; Elverfors A; Jonason J; Nissbrandt H
    Synapse; 1997 Feb; 25(2):215-26. PubMed ID: 9021902
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
    Lee CR; Abercrombie ED; Tepper JM
    Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dual effects of L-DOPA on nigral dopaminergic neurons.
    Guatteo E; Yee A; McKearney J; Cucchiaroni ML; Armogida M; Berretta N; Mercuri NB; Lipski J
    Exp Neurol; 2013 Sep; 247():582-94. PubMed ID: 23481547
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Opposite effects of mu and kappa opiates on the firing-rate of dopamine cells in the substantia nigra of the rat.
    Walker JM; Thompson LA; Frascella J; Friederich MW
    Eur J Pharmacol; 1987 Jan; 134(1):53-9. PubMed ID: 3030781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clomiphene blocks the effect of intravenous estradiol on the firing rate of rat nigral dopamine neurons.
    McCall WV; Ellinwood EH; Nishita JK; Lee TH
    Res Commun Chem Pathol Pharmacol; 1988 Apr; 60(1):141-4. PubMed ID: 3381008
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
    Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats.
    Diana M; Mereu G; Mura A; Fadda F; Passino N; Gessa G
    Brain Res; 1991 Dec; 566(1-2):208-11. PubMed ID: 1814536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Persistent supersensitivity of sigma receptors develops during repeated methamphetamine treatment.
    Ujike H; Okumura K; Zushi Y; Akiyama K; Otsuki S
    Eur J Pharmacol; 1992 Feb; 211(3):323-8. PubMed ID: 1352252
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activation of nigral dopamine neurons by the selective GABA(B)-receptor antagonist SCH 50911.
    Erhardt S; Nissbrandt H; Engberg G
    J Neural Transm (Vienna); 1999; 106(5-6):383-94. PubMed ID: 10443545
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons.
    Goldstein SR; Matsumoto RR; Thompson TL; Patrick RL; Bowen WD; Walker JM
    Synapse; 1989; 4(3):254-8. PubMed ID: 2558420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity.
    Smith ID; Grace AA
    Synapse; 1992 Dec; 12(4):287-303. PubMed ID: 1465742
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L; Pitts DK
    J Pharmacol Exp Ther; 1995 Jan; 272(1):164-76. PubMed ID: 7815330
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons.
    Freeman AS; Chiodo LA
    Brain Res; 1988 Jan; 439(1-2):266-74. PubMed ID: 3359189
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of dopamine agonists and antagonists on the electrical activity of substantia nigra neurons transplanted into the lateral ventricle of the rat.
    Wuerthele SM; Freed WJ; Olson L; Morihisa J; Spoor L; Wyatt RJ; Hoffer BJ
    Exp Brain Res; 1981; 44(1):1-10. PubMed ID: 7274357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.